|
|
Other links at Articles > Pharmacists |
| 2. |
Hypertension Potentiates the Risk of Doxorubicin Cardiotoxicity
|
|
|
Doxorubicin is often withheld from older patients because advanced age -- along with heart disease, diabetes, and hypertension -- are known to increase the risk of doxorubicin-related cardiotoxicity. Now, in a study of older adults with diffuse large B-cell lymphoma (DLBCL), researchers have found that of all these factors, only hypertension synergistically potentiates the risk of cardiac effects. Reuters Health Information
|
| 4. |
U.S. Lawmakers Seek Ex-Glaxo Executive on Avandia
|
|
|
Two U.S. lawmakers said on Tuesday they want to interview a former GlaxoSmithKline official as they probe whether a prominent diabetes doctor was pressured by the company for criticizing its drug Avandia. Reuters Health Information
|
| 5. |
First-Time Generic Approvals: Procardia XL, Estrostep FE, Estrostep
|
|
|
The FDA has approved first-time generic formulations for nifedipine extended-release tablets in 90-mg strength; norethindrone acetate and ethinyl estradiol tablets (28-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths; and norethindrone acetate and ethinyl estradiol tablets (21-day) in 1 mg/0.02 mg, 1 mg/0.03 mg, and 1 mg/0.035 mg strengths. Medscape Medical News
|
|
|
